Why I pivoted from COVID-19 back to cancer research. World view from SamraTurajlic, TheCrick
. This contributed to the prioritization of patients with blood cancer for additional vaccine doses, which boosted the proportion of protected patients.
We have now decided to end our COVID-19 research program, with the final follow up sample collected in April 2022. Our research protocol has been suspended but is ready to be reactivated if necessary. If cancer is treated as a health emergency, like COVID-19, translation and drug development can be accelerated. The time from drafting our COVID-19 study protocol to recruiting the first patient was 6 weeks, in contrast to the many months or even years needed for cancer research. This was achieved by faster ethics reviews and implementation of remote patient consenting and data collection. During the pandemic, in the UK alone over half a million people took part in research into COVID-19.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Penalties rolled back for Marines seeking COVID-19 vaccine exceptionsThe Marine Corps has rescinded some penalties placed on service members who have sought a religious exemption from a requirement to get the COVID-19 vaccination, such as promotion delays and administrative separations.
Read more »
Your Questions about the New COVID Booster Shots, AnsweredNew COVID booster vaccines built for the latest variants are here and should be more effective. But there are still some unknowns
Read more »
COVID deaths: more than 10 million children lost a parent or carerThe consequences of losing a parent can be profound, but the right support can reduce the impact.
Read more »
New York state shuts down COVID-19 data tracker for schoolsConcerned New York City parents noticed this week that a tracker for COVID-19 data across state schools now redirects to the New York State Department of Health’s main page on its COVID-19 response.
Read more »